Cargando…

Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas

BACKGROUND: To consolidate literature reports of serious late gastrointestinal toxicities after hypofractionated radiation treatment of pancreatic cancer and attempt to derive normal tissue complication probability (NTCP) parameters using the Lyman-Kutcher-Burman model. METHODS: Published reports of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elhammali, Adnan, Patel, Mukund, Weinberg, Benjamin, Verma, Vivek, Liu, Jingxia, Olsen, Jeffrey R., Gay, Hiram A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558934/ https://www.ncbi.nlm.nih.gov/pubmed/26337917 http://dx.doi.org/10.1186/s13014-015-0489-2

Ejemplares similares

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late‐reacting tissues
por: Böhlen, Till Tobias, et al.
Publicado: (2022)

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
por: Young, Kristina H., et al.
Publicado: (2016)

Heterotopia of salivary gland tissue in the pancreas
por: Martens, Sandrina, et al.
Publicado: (2023)

Radiation Therapy for Palliation of Sarcoma Metastases: A Unique and Uniform Hypofractionation Experience
por: Soyfer, Viacheslav, et al.
Publicado: (2010)

Late complications of pancreas transplant
por: Maupoey Ibáñez, Javier, et al.
Publicado: (2020)

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
por: Katz, Matthew H. G., et al.
Publicado: (2017)

Cost‐containment in hypofractionated radiation therapy: a literature review
por: Hunter, Darren, et al.
Publicado: (2018)

Hypofractionated radiation in secretory breast cancer: A case report
por: Tatebe, Ken, et al.
Publicado: (2021)

A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
por: Patel, Krishnan R., et al.
Publicado: (2022)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
por: Ogawa, Ayaka, et al.
Publicado: (2023)

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
por: Ciammella, Patrizia, et al.
Publicado: (2013)

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
por: Moore, Assaf, et al.
Publicado: (2019)

Peritransplant Varicosis After Simultaneous Pancreas and Kidney Transplantation Is an Uncommon Cause of Late-Onset and Recurrent Gastrointestinal Bleeding
por: Pfister, Matthias, et al.
Publicado: (2023)

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
por: Deantonio, Letizia, et al.
Publicado: (2010)

Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
por: Ogawa, Ayaka, et al.
Publicado: (2023)

Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms
por: Fega, Kathryn R., et al.
Publicado: (2018)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
por: Yu, Jeong Il, et al.
Publicado: (2016)

β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation
por: Sayeed, Aejaz, et al.
Publicado: (2016)

Hyperfractionated and Hypofractionated Radiation Therapy for Human Malignant Glioma Xenograft in Nude Mice
por: Hasegawa, Masatoshi, et al.
Publicado: (1995)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
por: Sayan, Mutlay, et al.
Publicado: (2019)

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021)

Volumetric Response of Limited Brain Metastatic Disease to Focal Hypofractionated Radiation Therapy
por: Wijetunga, Asanka R., et al.
Publicado: (2021)

Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
por: de Siqueira, Gabriela S.M., et al.
Publicado: (2022)

Does cost minimization of hypofractionated radiation therapy content all health stakeholders?
por: Melidis, Christos, et al.
Publicado: (2023)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study
por: Jorgo, Kliton, et al.
Publicado: (2019)

Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis
por: Ferini, Gianluca, et al.
Publicado: (2023)

Gastrointestinal Tract Heterotopic Pancreas: Asymptomatic Pathology?
por: Farah, Amir, et al.
Publicado: (2021)

Late, solitary metastatic renal carcinoma in the pancreas.
por: Simpson, N. S., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_vft1dj9s81lkqdbj95t5a8347d